68-Gallium DOTATATE (68Ga-DOTATATE)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68-Gallium DOTATATE (68Ga-DOTATATE), covering 2025-11-21 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. [Phase 4]